Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024 (Marina Temkin/TechCrunch)

May 30, 2026 - 04:26
Updated: 12 hours ago
0 0
Triomics logo. The company raised $22M Series B for its AI oncology platform.

Marina Temkin / TechCrunch:
Triomics, which is building an AI-powered platform to help oncologists automate data-heavy tasks, raised a $22M Series B, following a $15M Series A in 2024  —  Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks …

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Comments (0)

User